Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Linda Varga"'
Autor:
István Farkas, Gábor Sipka, Annamária Bakos, Anikó Maráz, Zoltán Bajory, Zsófia Mikó, Tamás Czékus, Szabolcs Urbán, Linda Varga, László Pávics, Zsuzsanna Besenyi
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Background: A large number of studies have proved that prostate-specific membrane antigen-positron emission tomography/computer tomography (PSMA-PET/CT) provides excellent accuracy in primary staging and restaging of prostate cancer. Less data exist
Externí odkaz:
https://doaj.org/article/a961cd042fed4ca1b667a7108f87b94f
Autor:
Linda Varga, Zsuzsanna Besenyi, Viktor R. Paczona, István Farkas, Szabolcs Urbán, Gábor Sipka, László Pávics, Zoltan Varga, Emese Fodor, Katalin Hideghéty, Judit Olah, Zoltán Bajory, Anikó Maráz
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionProstate-specific membrane antigen (PSMA) is a transmembrane protein that may be expressed on the surface of prostate cancer (PC) cells. It enables a more sensitive and specific diagnosis PC, compared to conventional anatomical imaging.Ai
Externí odkaz:
https://doaj.org/article/f107a7bea6394303a49c66b418931b62
Autor:
Janos Revesz, Boglarka Posfai, Laszlo Pajor, Timea Papdan, Linda Varga, Viktor R. Paczona, Zoltan Varga, Farkas Sukosd, Aniko Maraz
Publikováno v:
Pathology and Oncology Research, Vol 29 (2023)
Background: Programmed cell death (PD)-1/PD-ligand 1 (PD-L1) inhibitors have made a breakthrough in the therapy of advanced urothelial bladder cancer (UBC). The impact of Fibroblast Growth Factor Receptor 3 (FGFR3) mutation on the effectiveness of PD
Externí odkaz:
https://doaj.org/article/0c6e848e2d6246fabbff4a99f75c4bf2
Publikováno v:
Pathology and Oncology Research, Vol 28 (2023)
The renal angiomyolipoma (AML) is a benign tumor characteristically composed of fat, smooth muscle tissue, and vessels. We collected AMLs from our nephrectomy database, reclassified them according to their histological appearance, recorded the demogr
Externí odkaz:
https://doaj.org/article/dbae7baddfe1494daf31ebadd05ae03a
Autor:
Anikó Maráz, Adrienn Cserháti, Gabriella Uhercsák, Éva Szilágyi, Zoltán Varga, János Révész, Renáta Kószó, Linda Varga, Zsuzsanna Kahán
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background In patients with metastatic renal cell cancer, based on limited evidence, increased sunitinib exposure is associated with better outcome. The survival and toxicity data of patients receiving individualized dose escalated sunitinib
Externí odkaz:
https://doaj.org/article/db5ea6401a0a4868bae9430a4b6c2c44
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Magyar onkologia. 65(4)
Chemotherapy for the treatment of urothelial and bladder cancers has focused on renewed indications in light of clinical trials of modern therapies, which are described in our review. In stage T2-T4a N0-1 M0 cases, that are suitable for cisplatin, su
Autor:
Linda Varga
Prostate cancer (PC) is the second most common malignancy worldwide; the incidence is growing in every industrial country. Depending on the stage, surgical therapy, radiotherapy, and hormonal therapy are the potential therapeutic options. The elevati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2719c4d34622f72cfb550ed6212efe7
https://doi.org/10.14232/phd.10612
https://doi.org/10.14232/phd.10612
Publikováno v:
Magyar onkologia. 64(3)
The unprecedented development of prostate cancer therapy is a challenge for the proper sequential use of modern medicines. Patients' life expectancies improve when we use treatment lines, one after the other. There is no evidence- based guideline reg
Publikováno v:
Orvosi Hetilap. 159:1317-1325
Abstract: Introduction: Mortality of prostate carcinoma can be significantly decreased by the use of modern diagnostic and therapeutic options. Patients in early stages can be cured by radical surgery or radiotherapy. Aim: Overview and comparison of